In a study conducted by JUAN R. PALAZZO et al., involving 40 patients with BOTs, 80% of these tumors exhibited positive expression of P21WAF1/CIP1, which is significantly greater than that of both ovarian cancer and benign ovarian tumors. Here, CDKN1A is linked to ovarian cancer.